driven by the PitchBook Platform
Provider of anti-infective therapeutics and orphan drugs. The company researches and develops drugs for the treatment of serious lung infections which commonly affect children with cystic fibrosis.
You’re viewing a free company profile from the PitchBook Platform. To explore KeyBay Pharma’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.